Scientists have developed a blood test capable of detecting cancer years before current methods.
Researchers working for Oncimmune said the technique, which works by registering cancer cell by-products, has the potential to identify tumours up to five years before conventional tests.
The technology, due for launch in the UK next year, is based on the early work of breast cancer specialist Professor John Robertson, of The University of Nottingham.
Presentations on the method are due to be made at the American Society of Clinical Oncology’s annual conference in Chicago next week.
Oncimmune executive chairman Geoffrey Hamilton-Fairley said: “We believe this test, along with the others we will launch in the next few years, will lead to a better prognosis for a significant number of cancer sufferers.”
Cancer affects around 300,000 Britons every year, more than half of whom are killed by the disease.